Days at Home Among Dually Eligible Medicare Beneficiaries With Alzheimer Disease and Related Dementias - Summary - MDSpire

Days at Home Among Dually Eligible Medicare Beneficiaries With Alzheimer Disease and Related Dementias

  • By

  • Yutong Zhang

  • Yang Yang

  • Johanna Thunell

  • Katherine E. M. Miller

  • July 9, 2026

  • 0 min

Share

Objective:

To examine variations in days at home among older dually eligible persons living with dementia (PLWD) across states, including among home- and community-based services (HCBS) users.

Approach:
  • Study Design: Cross-sectional study using 2021 Medicare and Medicaid claims data to identify dually eligible beneficiaries.
  • Population: Included 523,150 unique dually eligible PLWD, aged 65 years and older.
  • Outcome Definition: Days at home defined as the number of days per year a patient was alive without any emergency department, hospital, or nursing home use.
  • Data Analysis: Described sample characteristics, HCBS use, and days at home; analyzed state-level variation.
Key Findings:
  • Mean days at home for older dually eligible PLWD was 238.1 days in 2021.
  • HCBS users had a mean of 275.0 days at home.
  • Substantial state-level variation in days at home, ranging from 159.3 days in Kentucky to 311.7 days in Alaska.
Interpretation:

Limitations:
  • Reduced generalizability due to exclusion of some states with Medicaid managed care programs.
  • Potential bias from differential attrition across states due to mortality.
  • Limited information on beneficiaries’ health and functional status.
Conclusion:

Original Source(s)

Related Content